Table 3.

Pharmacokinetic parameters for MTIP, CP154526, SSR125543A, and R121919

Compound/route/dose
MTIP CP154526 SSR125543A R121919
i.v. p.o. i.v. p.o. i.v. p.o. i.v. p.o.
1 mg/kg10 mg/kg3 mg/kg10 mg/kg3 mg/kg10 mg/kg3 mg/kg10 mg/kg
AUC0– t (ng · h/ml)3407 ± 27727,035 ± 3848568 ± 12355 ± 4411,634 ± 29489116 ± 1892154 ± 1378 ± 25
AUC0–∞ h (ng · h/ml)3435 ± 27531,290 (2)605 ± 16369 ± 3912,370 ± 316010,118 (2)164 ± 4381 ± 26
t ½ (h)3.9 ± 0.33.3 (2)15.1 ± 2.78.2 ± 1.410.53 ± 1.845.88 (2)2.8 ± 0.21.52 ± 0.07
C max (ng/ml)2773 ± 14866.5 ± 3.91603 ± 38777.8 ± 11.1
C 0 (ng/ml)4714 ± 19521274 ± 10425,744 ± 8468261 ± 11
t max (h)2.2 ± 1.04 ± 04.7 ± 1.82 ± 0
Clearance (ml · min−1 · kg−1)4.9 ± 0.482.7 ± 2.14.6 ± 1.1306 ± 7
V d, β (L/kg)1.7 ± 0.2114 ± 164.2 ± 0.875.7 ± 7.2
% Oral bioavailability91.118.324.569.7
  • n = 3, except where indicated otherwise in parentheses.